Position in ALNY
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$660,085
-$16,317 QoQ
Shares Held
1,995
+17.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HB Wealth Management, LLC holds $27,352,116 across 30 Biotechnology names. ALNY ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
50,237 | $8,491,057 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,287 | $4,593,556 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,436 | $2,654,791 | |
| 4 | TECH |
BIO-TECHNE Corp
|
34,140 | $1,784,156 | |
| 5 | EXEL |
Exelixis, Inc.
|
29,055 | $1,246,168 | |
| 6 | SABS |
SAB Biotherapeutics, Inc.
|
307,500 | $1,177,725 | |
| 7 | RPRX |
Royalty Pharma plc
|
18,229 | $874,445 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,995 | $660,085 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $660,085 | 1,995 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $676,402 | 1,701 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $673,056 | 1,476 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $283,372 | 869 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $208,185 | 771 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||